Sector
PharmaceuticalsOpen
₹3.48Prev. Close
₹3.32Turnover(Lac.)
₹0Day's High
₹3.48Day's Low
₹3.4852 Week's High
₹3.4852 Week's Low
₹2.5Book Value
₹-6.06Face Value
₹10Mkt Cap (₹ Cr.)
1.49P/E
0EPS
0Divi. Yield
014 Aug 2024
12:00 AM
AGM
Announcement Date: 14 Aug, 2024
29 Mar 2025
12:00 AM
EGM
15 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 4.27 | 4.27 | 4.27 | 4.27 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -6.68 | -6.58 | -6.41 | -6.33 |
Net Worth | -2.41 | -2.31 | -2.14 | -2.06 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 |
yoy growth (%) | 0 | 0 | 0 | 0 |
Raw materials | 0 | 0 | 0 | 0 |
As % of sales | 0 | 0 | 0 | 0 |
Employee costs | -0.02 | -0.01 | -0.01 | -0.01 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -0.06 | -0.02 | -0.02 | -0.02 |
Depreciation | 0 | 0 | 0 | 0 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | 0.08 | -0.06 | -0.04 | 0 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | 0 | 0 | 0 |
Op profit growth | 129.2 | -8.19 | 3.76 | 26.28 |
EBIT growth | 196.15 | -16.65 | 3.01 | 79.79 |
Net profit growth | 23.59 | -1.66 | 13.34 | 33.05 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Harsh Prabhakar
Independent Director
Poonam Sharma
Managing Director & CFO
Prashant Nathmal Bajaj
Non Executive Director
Hitesh Bajoria
Non Executive Director
Tushar Pandit Awate
Non Executive Director
Urmila Hansraj Sharma
Non Executive Director
Nishant Nathmal Bajaj
103 Emperor 1 Sector 93A,
Supertech Emerald Court,
Uttar Pradesh - 201304
Tel: 91-0120-2426900/9412700300
Website: -
Email: raymedlabs@rediffmail.com
Beetal House 99,
Madangir Behind LSC, Nr Dada Harsukhdar,
Delhi - 110062
Tel: 91-011-29961281
Website: -
Email: beetalrta@gmail.com
Summary
Raymed Labs Limited was established in 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities on Dehradun Road, Saharanpur, UP. The Company embark...
Read More
Reports by Raymed Labs Ltd
What is the Raymed Labs Ltd share price today?
What is the Market Cap of Raymed Labs Ltd?
What is the PE and PB ratio of Raymed Labs Ltd?
What is the 52 Week High and Low of Raymed Labs Ltd?
What is the CAGR of Raymed Labs Ltd?
What is the shareholding pattern of Raymed Labs Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.